Submission based on data from pivotal CARTITUDE-1 trialSOMERSET, N.J. (BUSINESS WIRE) $LEGN Legend Biotech Corporation (NASDAQ: LEGN), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced today the submission of a New Drug Application (NDA) to the Japanese Ministr.
Parque de cerejeiras esconde história de Olimpíada cancelada pela guerra uol.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uol.com.br Daily Mail and Mail on Sunday newspapers.